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ABSTRACT The type II voltage-dependent sodium chan-
nel is present in neuronal cells, where it mediates the prop-
agation of nerve impulses. Restricted expression of the type II
sodium channel gene to neurons is due, at least in part, to
binding of the repressor protein REST (also termed NRSF or
XBR) to the RE1 (also called NRSE) sequence in the type II
sodium channel gene. Previous studies have shown that a
domain in REST containing eight GL1-Kru¨ppel zinc finger
motifs mediates DNA binding. Deletional and GAL4-fusion
gene analyses now reveal repressor domains that lie outside of
the DNA-binding domain in both the amino and carboxyl
termini of REST. Mutational analysis further identifies a
single zinc finger motif in the carboxyl-terminal domain as
being essential for repressing type II sodium channel reporter
genes. These studies reveal two domains in REST that may
mediate interactions with other proteins involved in restrict-
ing expression of a large set of genes to the vertebrate nervous
system.
The ability to generate action potentials is often due to the
presence of voltage-dependent sodium channels in the plasma
membranes of the excitable cells. Sodium channels are en-
coded by a large multigene family, and members of this family
are structurally distinct and expressed in a tissue-specific
manner (reviewed in ref. 1). The type II sodium channel gene
(2, 3) is expressed to high levels exclusively in neurons in the
central nervous system (4, 5). Because of this selective expres-
sion pattern, the type II sodium channel has provided an
excellent model for studies of the mechanisms regulating
neural-specific gene expression.
Type II sodium channel reporter genes containing 1050 bp
of 59 f lanking sequence are expressed in neuronal cell lines but
not in nonneuronal cells, consistent with expression of the
endogenous gene. Deletional analysis has identified a 23-bp
element in the type II sodium channel regulatory region,
termed repressor element 1 (RE1), that prevents expression of
type II reporter genes in nonneuronal cell types (6, 7).
Removal of the RE1 results in approximately 80-fold dere-
pression of the type II sodium channel reporter gene specifi-
cally in nonneuronal cell types. Repressor elements with
sequences and functional properties similar to those of the type
II sodium channel RE1 are present in the regulatory region of
several other genes expressed exclusively in the nervous system
(reviewed in ref. 8), including SCG10 (9, 10), synapsin (11), the
b1 subunit of the nicotinic acetylcholine receptor (12), the
muscarinc M4 receptor (13, 14), and neural–glial cell adhesion
molecule (15). The widespread occurrence of RE1-like se-
quences in different genes suggests a more global role of
repression in restricting gene expression to the nervous system.
Recombinant RE1-silencing transcription factor (REST) is
sufficient to repress reporter genes containing RE1-like target
sequences in cotransfection analyses of neuronal cells (8, 16,
17). The deduced primary structure of REST does not reveal
any amino acid homologies which would point to repressor
domains. However, previous studies suggested that the DNA-
binding and repressor domains of REST were physically
distinct. The REST DNA-binding domain was identified orig-
inally, in a genetic screen in yeast, as a cluster of eight
GL1-Kru¨ppel class C2H2 (Cys2His2) zinc fingers (16). Expres-
sion in skeletal muscle cells of a portion of REST containing
these zinc fingers resulted in derepression of cotransfected
type II reporter genes (16). This result suggested that the
amino-terminal zinc fingers were acting as a dominant negative
mutant by interfering with binding of the endogenous REST
protein to the RE1 target site. The result further suggested that
the domains required for repression must be located elsewhere
in the molecule.
It is clear, from studies of both prokaryotes and eukaryotes,
that several different mechanisms have evolved for repressing
gene expression. Despite the importance of negative gene
regulation, the molecular components required for this mech-
anism are only beginning to emerge. REST-mediated repres-
sion is cell-type specific, and REST represses minimal pro-
moters that do not require activators for transcription (6, 9).
Thus, REST provides an excellent model for studying the
molecular basis of this class of repressors. In this study we
sought to perform a structure–function analysis of REST for
the purpose of elucidating potentially important domains by
which REST might interact with the transcriptional machin-
ery.
We have identified, using a deletional and GAL4-fusion
gene approach, two distinct repressor domains in REST. As
predicted by the earlier studies, expression of the DNA-
binding domain alone in neuronal PC12 cells did not result in
repression of type II reporter genes. Rather, distinct domains
in the amino and carboxyl termini were identified that were
each partially required and sufficient to repress the type II
promoter. The carboxyl-terminal domain contains a predicted
zinc finger motif, and mutations that destroy the finger struc-
ture abolish repression. It is likely that the two REST domains
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are sites of interactions with other factors that are required for
repression of the set of genes containing RE1 sequences.
METHODS
Plasmid Constructions. The plasmid REEX1 (amino acids
1–1097) is a derivative of the plasmid REST-EXPRESS (16)
generated by subcloning a 4.03-kb EcoRI fragment containing
the entire REST coding sequence into the EcoRI site of
pcDNAI-Amp (Invitrogen). Constructs encoding partial seg-
ments of the REST protein were generated as follows: A
partial cDNA clone termed p73 (amino acids 73–545), con-
taining the deduced eight zinc fingers of the DNA-binding
domain, has been described (16). REEX21 (amino acids
73–636) was created by a three-way ligation of a HindIIIy
HincII fragment of p73 with a HincIIySphI fragment of
REEX1 between the HindIII and SphI sites of pcDNAI-Amp.
REEX21 extends p73 by 91 amino acids. REEX7, containing
an internal deletion between amino acids 636 and 786, was
constructed by a three-way ligation of an EcoRIyblunted SphI
fragment of REEX1 with a blunted BstXIyXbaI fragment of
REEX1 inserted between the EcoRI and XbaI sites of pc
DNAI-Amp. REEX9 (amino acids 1–1036) was generated by
ligation of an EcoRIySphI fragment of REEX1 and a SphIy
EaeI fragment of REEX1 between the EcoRI and NotI sites
of pcDNAI-Amp. REEX8 (amino acids 73–1097) was created
by subcloning a PvuIIyXbaI fragment of REEX1 between the
EcoRV and XbaI sites of pcDNAI-Amp. The orientation of all
recombinant REST constructs was confirmed by restriction
analysis, and REST deletional mutants were also checked by
sequence analysis to ensure that frameshifts had not occurred.
The plasmid pSG424 containing the GAL4 DNA-binding
domain (amino acids 1–147) was obtained from Stan Fields
(University of Washington, Seattle). To construct GAL4-N1,
the amino-terminal sequences of REST (amino acids 1–83)
were obtained by the polymerase chain reaction (PCR) using
REEX1 as the template. The PCR products were digested with
BamHI and KpnI restriction enzymes and subcloned into the
pSG424 vector. GAL4-REEX1 was generated by three-way
ligation of a BamHIyPvuII fragment of GAL4-N1 with a
PvuIIyXbaI fragment of REEX1 between the BamHI and
XbaI sites of pSG424. GAL4-p73 (amino acids 62–545 of
REST) was generated by first ligating a PvuIIyXbaI fragment
of GAL4-REEX1 between the SmaI andXbaI sites of pSG424,
generating GAL4-REEX8. Second, a ClaIyXbaI fragment of
p73 was ligated between the ClaIyXbaI sites of GAL4-
REEX8, resulting in GAL4-p73. To construct GAL4-C3,
REST amino acids from 1008 to 1097, containing the single
zinc finger, were amplified by the PCR and the fragment was
subcloned into the pSG424 backbone at the BamHI site. All of
the GAL4-REST fusions were sequenced across the GAL4-
REST junction to ensure that the inserts were in frame with
GAL4. All constructs generated by the PCR were fully se-
quenced to ensure that mutationsydeletions had occurred
during the amplification reaction.
The RE1-containing type II sodium channel-chloramphen-
icol acetyltransferase (CAT) reporter gene, pSDK7, has been
described previously (7). The upstream activating sequence
(UAS) type II CAT reporter gene was generated by substitut-
ing the 23-nucleotide type II RE1 sequence in the CAT
reporter plasmid for five copies of the UAS from the plasmid
pGAL4-TKCAT provided by Thomas Shenk, Princeton Uni-
versity (18).
Site-Directed Mutagenesis. To generate a mutant REST
molecule with an amino acid change in the predicted carboxyl-
terminal zinc finger motif, a commercial DNAmutagenesis kit
was used (Morph, 5 Prime 3 3 Prime). An oligonucleotide
encoding a mutation in a cysteine residue of the zinc finger was
synthesized. This oligonucleotide, 59-GCGGCTAAGG-
GAGATTTTGTTCGTATCTTCTGTGATCG-39, was used
to construct the mutant GAL4-C3M1. The fragment was
checked by sequence analysis. (The boldface letter represents
the change from wild-type sequence.) The mutation results in
the substitution of an arginine residue for a cysteine. To
generate an intact REST molecule containing the mutation in
the carboxyl-terminal zinc finger, an EcoRIyEagI fragment of
REEX1 and an EaeIyXbaI fragment of GAL4-C3M1 were
ligated into the pcDNA1-Amp vector at the EcoRI and XbaI
sites.
Transient Transfections and CAT Assays. PC12 cells were
grown as described previously (19). COS-1 cells were grown in
Dulbecco’s modified Eagle’sMedium (DMEM) supplemented
with 10% bovine calf serum (HyClone). COS-1 cells were
transfected with 8 mg of plasmid DNA by treatment with
calcium phosphate (20). For the transfections shown in Fig. 1,
PC12 cells were electroporated with mixtures of 10 mg of
reporter plasmid containing either 5 mg of empty pcDNAI-
Amp vector or 10 mg of pcDNAI-Amp plasmids containing
REST cDNA inserts. For the transfections shown in Fig. 2,
PC12 cells were electroporated with mixtures of 10 mg of
reporter plasmid and 5 mg of pSG424 or equimolar (to 5 mg of
pSG424) amounts of GAL4-REST fusion cDNA constructs.
To all mixtures, pBluescript II SK (Stratagene) was added to
bring the final amount of DNA to 20 mg. For the transfections
shown in Fig. 3, 10 mg of reporter plasmid was mixed with
either 1 mg of pcDNAI-Amp or an equimolar amount of
pcDNAI-Amp containing REST inserts. The mixture of cells
and DNA was chilled on ice for 5–10 min before electropo-
ration (250 mV, 960 mF). Following electroporation the cells
were chilled on ice for a further 10 min before plating in
100-mm dishes. Medium was changed 24 hr after transfection
and cells were harvested after 48 hr. The protein concentration
of the cell lysates was determined with the micro BCA protein
assay reagent (Pierce) in microtiter plates. Assays for CAT
activity in lysates of the harvested cells were performed as
described previously (7). Relative activity of the extracts was
calculated by determining the percentage of acetylated chlor-
amphenicol, using a Molecular Dynamics PhosphorImager.
For each construct at least two different preparations of
plasmid DNA were used (Qiagen from Qiagen or JetStar from
Genomed). In each experiment, constructs were transfected in
duplicate and different experiments were performed several
times as noted in Results.
Western Blot Analyses. Nuclear extract preparation and
Western blotting of COS-1 cells transfected with the appro-
priate cDNA constructs were performed as described previ-
ously (16), and the samples were solubilized in Laemmli
sample buffer. After separation on reducing SDSypolyacryl-
amide gels, either 7% or 12% polyacrylamide, proteins were
transferred onto nitrocellulose membranes. Blots were incu-
bated either with a polyclonal anti-GAL4 antibody (Upstate
Biotechnology) or an affinity-purified polyclonal anti-REST
antibody. The antibodies were visualized by using the ECL
detection method (NEN).
RESULTS
Two Distinct Domains in REST Are Involved in Repression
of Type II Sodium Channel Reporter Genes in PC12 Cells.
Although no known repressor consensus sequences were ap-
parent in the deduced primary sequence of REST, three
distinct domains, depicted in Fig. 1, were identified. These
domains, from amino terminus to carboxyl terminus, consisted
of the following: (i) a cluster of eight GLI-Kru¨ppel type zinc
fingers constituting the DNA-binding domain (16, 17), (ii) a
novel reiterated proline-rich motif, and (iii) a single C2H2 zinc
finger motif in the carboxyl terminus. Here, we have generated
a family of deletion molecules to examine the potential in-
volvement of these motifs in transcriptional repression by
REST. The REST cDNAs were placed under control of the
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CMV 1E promoter in the mammalian expression vector
pcDNA1 (Fig. 1). The constructs were cotransfected into PC12
cells, which do not express significant levels of the endogenous
REST gene, along with CAT reporter genes containing the
type II sodium channel RE1 sequence upstream of the type II
promoter. CAT activity resulting from cotransfection of the
type II reporter gene and the empty vector was set to 100%.
Cotransfection of PC12 cells with the type II sodium channel
reporter gene and the full-length REST cDNA (REEX1)
caused a greater than 7-fold repression of reporter gene
expression (13.3% CAT activity; Fig. 1). Because the domain
containing the cluster of eight zinc fingers is required for DNA
binding to the RE1 sequence (16) this domain must be
included in all of the REST deletional mutants. As expected,
expression of the REST DNA-binding domain alone (p73) did
not result in repression of the type II reporter gene. In fact,
CAT activity of this mutant was slightly greater than that of the
control value, perhaps representing a slight dominant inter-
fering effect from competition for RE1 binding by the low
levels of REST protein that are present in PC12 cells (ref. 16;
see also results with GAL4-p73 in Fig. 2B). Inclusion of a
region adjacent to the DNA-binding domain caused only a
modest increase in repressor activity (75% CAT activity; Fig.
1). The domain containing the six reiterated proline-rich
motifs was also deleted from the intact REST molecule
(REEX7). The removal of this domain did not interfere with
repressor activity (Fig. 1), indicating that these motifs are not
required for the repressor mechanism.
Expression of a truncated REST molecule lacking the 60
terminal amino acids of REST that includes the lone zinc
finger motif (REEX9) resulted in a partial derepression of the
type II promoter, causing an approximately 3-fold increase in
CAT activity compared with that mediated by the wild-type
REEX1molecule. Thus, of all of the obvious domains revealed
by elucidation of the REST primary sequence, only the
carboxyl-terminal zinc finger domain exhibited significant
repressor activity. However, the requirement for this domain
was only partial, suggesting that other domains in REST were
also required to mediate repression. In support of this inter-
pretation, a partial cDNA extending from the predicted ini-
tiator methionine in NRSF to amino acid 585 also exhibited
repressor activity in transient transfection analyses (17). By
process of elimination in comparing the predicted structures of
the partial NRSF protein and full-length RESTyNRSF, an-
other candidate for a repressor domain was the amino termi-
nus of REST that was missing in the DNA-binding domain
construct, p73. Results of transfections with a REST mutant
that lacks these amino acids (REEX8) showed that the amino-
terminal domain was partially required for repression of type
II sodium channel reporter gene expression (37.3% CAT
activity; Fig. 1). The amount of repression exhibited by the
REST mutants deleted in the amino- and carboxyl-terminal
domains were roughly equivalent (approximately 3-fold re-
pression of reporter gene activity for each construct).
To determine whether the amino- and carboxyl-terminal
domains were sufficient to mediate repression, repressor ac-
tivity of the individual domains was tested by fusing them
in-frame to cDNA coding for the DNA-binding domain of the
yeast activator protein GAL4. Correspondingly, in the type II
sodium channel reporter gene, the type II RE1 was replaced
with five copies of the yeast UAS, the target site for binding
by the GAL4 protein. The chimeric cDNAs and UAS reporter
genes were then cotransfected into PC12 cells. The activity of
the UAS type II reporter gene coexpressed with the GAL4
DNA-binding domain alone was set at 100%.
To validate this system for analyzing REST repressor activ-
ity, a chimeric protein containing the full-length REST protein
(GAL4-REEX1; Fig. 2A) was first introduced into PC12 cells
along with the UAS reporter gene. As expected, CAT activity
of GAL4-REEX1 was repressed approximately 4-fold com-
pared with control CAT activity (Fig. 2B). To determine
whether the 83 amino-terminal (GAL4N1; Fig. 2A) or 88
carboxyl-terminal (GAL4C3; Fig. 2A) amino acids were suf-
ficient tomediate repression in this system, these domains were
also fused in-frame with the GAL4 DNA-binding domain.
Expression of these REST domains resulted in dramatic
repressor activity, 9.5-fold and 11-fold, respectively (Fig. 2B),
indicating that they were indeed sufficient to mediate repres-
sion of UAS reporter gene expression. In contrast to these
results, transfections with the GAL4-p73 fusion gene (Fig.
2A), encoding the eight Kru¨ppel type zinc fingers in the
DNA-binding domain, did not result in repression of reporter
gene activity (Fig. 2B).
Mutation of the Single Zinc Finger in the Carboxyl-
Terminal Domain Abrogates Repression. Unlike the amino-
terminal domain, the carboxyl-terminal domain that was suf-
ficient to repress the type II sodium channel promoter con-
tained a recognizable motif, a single C2H2 zinc finger. To test
FIG. 1. Domains in the amino and carboxyl termini of REST are required, in part, to mediate repression of type II sodium channel reporter
genes. The family of REST molecules expressed under control of the cytomegalovirus (CMV) promoter, in PC12 cells, is shown with respect to
the presence of known motifs in the deduced primary structure of REST (top line). The dotted lines indicate the regions in REST that were deleted.
A cartoon of the cotransfected reporter gene shows the positions of the type II repressor element 1 (RE1), type II sodium channel promoter (type
II) and CAT gene (bottom line). Arrows indicate the start sites for transcription in the expression plasmids. On the right, the percent activity of
CAT resulting from transfection of the different constructs is normalized to that from the vector alone, which is set to 100%. Standard errors of
the mean and (in parentheses) the numbers of experiments are indicated.
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whether this motif was required for repression by REST, one
of the cysteine residues critical for the zinc finger structure was
changed to an arginine, and the mutated domain was fused
in-frame with the GAL4-DNA-binding domain. The mutated
construct (GAL4C3M1) was cotransfected into PC12 cells
along with the UAS type II reporter gene (Fig. 2B). The zinc
finger mutation abolished the repressor activity normally
observed with the corresponding wild-type REST domain (the
CAT activity was equivalent to that seen by expression of the
control GAL4 and GAL4-p73 constructs). Western blot anal-
ysis of COS-1 cells transfected with the GAL4 fusion genes
indicated that the lack of repression by the mutated carboxyl-
terminal zinc finger domain (GAL4-C3M1) and by the REST
p73 domain was not due simply to differences in the levels of
expressed chimeric proteins (Fig. 2C). Repression of reporter
gene activity mediated by the GAL4-REST fusion proteins
required the REST domains to be tethered to the DNA
through the GAL4 DNA-binding domain because transfec-
tions of the GAL4-REST constructs with a type II reporter
gene lacking an UAS did not result in repression of CAT
activity (data not shown).
The above studies indicated that the single zinc finger motif
was required for repression mediated by the carboxyl-terminal
REST domain. To determine whether the zinc finger motif was
also required for repression within the context of the intact
REST molecule, the cysteine-to-arginine point mutation was
introduced into the full-length REST molecule REEX1 and
cotransfected with the RE1-type II sodium channel reporter
gene into PC12 cells (Fig. 3). The point mutation in REEX1
(REEX1M1) resulted in a partial derepression of the type II
promoter (4.5-fold increase in CAT activity compared with
wild-type REEX1; Fig. 3B). The residual repressor activity is
likely due to the presence of the amino-terminal fragment
shown above to be sufficient to partially mediate repression.
Transfection of the wild-type and mutant cDNAs into COS-1
cells resulted in the expression of a 200-kDa protein that was
detected by an anti-REST antibody (Fig. 3C). The reduced
repressor activity of mutated REST was not due to reduced
accumulation of the protein, because Western blot analysis
indicated similar levels of expression of the wild-type and
mutant proteins (Fig. 3C).
DISCUSSION
The molecular mechanisms responsible for regulating expres-
sion of genes in the nervous system are understood poorly.
FIG. 2. Domains in the amino and carboxyl termini of REST are sufficient to mediate repression, and a point mutation in the zinc finger motif
abrogates repressor activity. (A) Schematic representation of the family of GAL4-REST chimerical cDNAs expressed with a UAS type II-CAT
reporter gene in transient transfections of PC12 cells. The reporter gene contains five copies of the UAS. The dotted lines indicate regions in REST
that were deleted. Arrows indicate start sites for transcription. The carboxyl-terminal (C3), amino-terminal (N1), and mutated carboxyl-terminal
(C3M1) fragments of REST are in-frame with the DNA-binding domain of the GAL4 protein. (B) (Left) Representative autoradiogram showing
thin-layer chromatography (TLC) fractionation of acetylated forms of chloramphenicol. Each sample is from a dish of cells transfected transiently
with the GAL4-REST chimerical cDNA and the UAS type II reporter gene. Note that the CAT assay with the GAL4-p73 construct was from a
different TLC plate. (Right) Histogram showing compiled data from independent experiments. Standard errors of the mean and the numbers of
experiments are indicated. (C) Western blot analysis of COS-1 cells transfected with the indicated GAL4-REST carboxyl-terminal (C3 and C3M1)
and GAL4-p73 constructs. The amounts of the expressed proteins (arrowheads) show that the inability of the mutated carboxyl-terminal fragment
C3M1 and p73 to repress is not due to instability of the expressed protein.
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However, recent studies have shown that at least one of these
mechanisms involves transcriptional repression mediated by
the DNA-binding protein REST. The discovery that REST is
also involved in regulating the expression of many other genes
expressed in the nervous system, through a common RE1-like
genetic element, underscores the importance of elucidating
the molecular mechanism by which REST repression is me-
diated.
Eukaryotic transcription can be prevented by mechanisms
that are dependent upon (silencing) or independent of (re-
pression) chromatin structure (for review see ref. 21). The
observation that REST can inhibit reporter gene expression in
transient transfection analyses with plasmid DNA suggests that
chromatin remodeling is not required for its ability to block
transcription, and classifies REST as a repressor. Two well
characterized domains have been shown to mediate the activ-
ities of other repressor proteins, a domain that is rich in alanine
residues (22–24), and a Kru¨ppel-associated box A (KRAB-A)
domain, rich in charged amino acids, that is present in a large
number of zinc finger proteins (25, 26). The deduced primary
structure of full-length REST (refs. 16 and 27, and D. Ander-
son, personal communication) does not contain either of these
motifs.
The cluster of eight GL1- Kru¨ppel type zinc fingers in REST
binds to the type II RE1 sequence in vivo and in vitro (16, 17).
Despite the ability to bind DNA, they are not sufficient to
mediate repression. An additional C2H2 zinc finger motif
resides in the deduced carboxyl terminus of REST. The
deletional and GAL4 fusion gene analyses performed in this
study indicated that, unlike the DNA-binding domain, this
domain was partially required and sufficient to mediate re-
pression of type II sodium channel reporter genes. In fact, the
amount of repression mediated by the GAL4-carboxyl-
terminal fusion protein was even greater than that mediated by
repression of the GAL4-REST chimera containing the entire
REST sequence. It is possible that the zinc finger motif in the
isolated carboxyl-terminal domain is more accessible to other
components involved in the repression mechanism than when
embedded in the intact REST molecule. To exclude the
possibility that all small fragments fused to GAL4 will mediate
repression in this system, we examined two additional REST
fragments of a size similar to that of the carboxyl-terminal
domain. The small GAL4-REST fusion proteins do not exhibit
repressor activity (data not shown). Furthermore, the carbox-
yl-terminal domain containing a single point mutation in the
zinc finger motif also does not exhibit repressor activity.
Zinc finger motifs in proteins are usually associated with
DNA binding (for review see ref. 28). The zinc fingers can also
mediate protein–protein interactions (29–34), and some of the
proteins that contain zinc finger motifs are transcriptional
repressors. However, to our knowledge, REST is the first
example whereby a zinc finger structure is required to mediate
repression. For example, in the transcription factor YY1,
although an identified repressor domain contained two zinc
fingers, mutational analysis indicated that the structures of
these zinc fingers were not required for repression (35). It may
be that the zinc finger motif in REST is sufficient to mediate
repression, although flanking amino acid sequences may also
contribute to the ability of the minimal 23 amino acid motif to
repress. Interestingly, in the transcription factor TFIIIA, the
linker sequence characteristic of Kru¨ppel type zinc fingers has
been shown to confer high-affinity DNA binding on the zinc
finger domain (36). This linker sequence is present in the
Kru¨ppel type zinc fingers that constitute the DNA-binding
domain in REST. The zinc finger motif in the carboxyl-
terminal domain of REST that mediates repression, as a single
structure, does not have this linker sequence and does not
appear to bind DNA. For example, in transient transfection
analysis, chimeric GAL4 proteins containing the carboxyl-
terminal domain of REST, and thus the zinc finger, do not
repress type II sodium channel reporter genes containing the
RE1 sequence in place of the UAS (J.T.-R. and G.M.,
unpublished results). Although we cannot formally exclude the
possibility that this zinc finger motif binds to DNA (but see ref.
27), it does not appear to bind to the type II RE1 sequence.
The deletional and fusion gene studies herein have revealed
the presence of two distinct repressor domains located at
opposite ends of the REST molecule. Indeed, the REST
amino-terminal domain fused to GAL4 is as effective in
mediating repression of the type II promoter as is the carboxyl-
terminal domain. Further, like the zinc finger domain, the
amino-terminal domain is also partially required for repres-
FIG. 3. The single C2H2 zinc finger in the carboxyl terminus of REST is sufficient to mediate repression of type II sodium channel reporter
genes. (A) Schematic representation of the REST expression vector and type II-CAT reporter genes. Relative locations of distinct domains in REST
are indicated. (B) Representative autoradiogram (Left) shows TLC fractionation of acetylated forms of chloramphenicol from PC12 cells
cotransfected with the different REST constructs shown and the RE1-type II-CAT reporter gene. Other symbols are the same as in Fig. 1. A
histogram (Right) shows a compilation of CAT activity from four independent experiments using the REST constructs indicated for the
autoradiogram. Standard errors of the mean are shown. (C) Western blot analysis of COS cells transfected with the wild-type (REEX1) andmutated
(REEX1M1) cDNAs. Upper arrowhead denotes overexpressed REST protein (200 kDa) and lower arrowhead denotes cross-reacting endogenous
protein migrating at 116 kDa (16).
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sion. No obvious motifs are present within the amino-terminal
sequences. However, future studies, such as comparisons with
REST homologues in other species, may help clarify the
functional motifs.
Many repressor complexes consist of a DNA-binding protein
interacting with corepressors. Examples of such complexes are
thyroid hormone and retinoic acid receptors and the TRACs
(37, 38), MadyMaxysin3 (39), yeast TUP1ySSN6 and several
different DNA-binding proteins (e.g., see ref. 40), the imme-
diate early proteins NAB1yNGF1AyKROX20 (41), and Dro-
sophilaHairy-related proteins and Groucho (42, 43). It is likely
that the amino-terminal and zinc finger domains now identi-
fied in REST interact with corepressor proteins or with
proteins that are part of the initiation complex.
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